(Q47219086)

English

Cost effectiveness of antiviral treatment with zalcitabine plus zidovudine for AIDS patients with CD4+ counts less than 300/microliters in 5 European countries

scientific article published in December 1994

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10155284

Cost effectiveness of antiviral treatment with zalcitabine plus zidovudine for AIDS patients with CD4+ counts less than 300/microliters in 5 European countries (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10155284

1 reference

based on heuristic

inferred from title

author name string

K Simpson

1

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10155284

E J Hatziandreu

2

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10155284

F Andersson

3

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10155284

A Shakespeare

4

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10155284

I Oleksy

5

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10155284

A N Tosteson

6

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10155284

publication date

1 December 1994

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10155284

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10155284

6

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10155284

6

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10155284

553-562

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10155284

https://scigraph.springernature.com/pub.10.2165/00019053-199406060-00008

0 references

Zidovudine: a review of pharmacoeconomic and quality-of-life considerations for its use in patients with human immunodeficiency virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimycobacterial therapy for disseminated Mycobacterium avium complex infection in patients with acquired immunodeficiency syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression and clinical outcome of infection due to human immunodeficiency virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treating AIDS: the economic issues

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AIDS surveillance in Europe: status at 31st March 1992. European centre for the epidemiological monitoring of AIDS

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of AIDS with combinations of antiretroviral agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medication costs associated with the care of HIV-infected patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical economics. A guide to the economic analysis of clinical practices

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary analysis of the Concorde trial. Concorde Coordinating Committee

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health services needs and related costs for HIV care

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Projecting the medical costs of AIDS and ARC in the United States.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival trends for patients with AIDS.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modeling the relationship between survival and CD4 lymphocytes in patients with AIDS and AIDS-related complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Issues in the cross-national assessment of health technology

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Completeness of AIDS reporting in Switzerland: a study based on deaths between December 1987 and June 1990

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The lifetime cost of treating a person with HIV.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Markov process in medical prognosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Zidovudine: five years later

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD4 Count and the Risk for Death in Patients Infected with HIV Receiving Antiretroviral Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary prophylaxis for Pneumocystis carinii pneumonia in HIV-infected people with CD4 counts below 200/mm3: a cost-effectiveness analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10155284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-199406060-00008

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10155284

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10155284

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47219086&oldid=2146705793"